SUVEN LIFE SCIENCES
|
SUVEN LIFE SCIENCES Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹15 Cr | ₹13 Cr |
| Equity - Authorised | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹20 Cr | ₹20 Cr |
| Equity - Issued | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹15 Cr | ₹13 Cr |
| Equity Paid Up | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹15 Cr | ₹13 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
| Share Warrants & Outstandings | ₹1.28 Cr | - | - | - | ₹37 Cr |
| Total Reserves | ₹87 Cr | ₹248 Cr | ₹354 Cr | ₹82 Cr | ₹58 Cr |
| Securities Premium | ₹647 Cr | ₹647 Cr | ₹647 Cr | ₹257 Cr | ₹111 Cr |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹-601 Cr | ₹-440 Cr | ₹-335 Cr | ₹-217 Cr | ₹-95 Cr |
| General Reserves | ₹43 Cr | ₹43 Cr | ₹43 Cr | ₹43 Cr | ₹43 Cr |
| Other Reserves | ₹-2.57 Cr | ₹-2.04 Cr | ₹-1.90 Cr | ₹-1.75 Cr | ₹-1.31 Cr |
| Reserve excluding Revaluation Reserve | ₹87 Cr | ₹248 Cr | ₹354 Cr | ₹82 Cr | ₹58 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹110 Cr | ₹270 Cr | ₹375 Cr | ₹96 Cr | ₹108 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | - | - | - | - | ₹0.39 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | ₹1.34 Cr |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | ₹-0.94 Cr |
| Deferred Tax Assets / Liabilities | - | - | - | - | - |
| Deferred Tax Assets | - | - | - | - | - |
| Deferred Tax Liability | - | - | - | - | - |
| Other Long Term Liabilities | - | - | ₹0.58 Cr | ₹1.57 Cr | ₹2.38 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹1.71 Cr | ₹1.35 Cr | ₹1.88 Cr | ₹2.00 Cr | ₹1.73 Cr |
| Total Non-Current Liabilities | ₹1.71 Cr | ₹1.35 Cr | ₹2.46 Cr | ₹3.58 Cr | ₹4.50 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹5.23 Cr | ₹2.07 Cr | ₹1.67 Cr | ₹1.99 Cr | ₹3.00 Cr |
| Sundry Creditors | ₹5.23 Cr | ₹2.07 Cr | ₹1.67 Cr | ₹1.99 Cr | ₹3.00 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹17 Cr | ₹10 Cr | ₹8.44 Cr | ₹5.44 Cr | ₹12 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | - | - | ₹0.00 Cr | - | ₹0.02 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹17 Cr | ₹10 Cr | ₹8.44 Cr | ₹5.44 Cr | ₹12 Cr |
| Short Term Borrowings | - | - | - | - | - |
| Secured ST Loans repayable on Demands | - | - | - | - | - |
| Working Capital Loans- Sec | - | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | - | - | - | - | - |
| Short Term Provisions | ₹1.64 Cr | ₹1.12 Cr | ₹95 Cr | ₹95 Cr | ₹95 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | - | - | ₹94 Cr | ₹94 Cr | ₹94 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹1.64 Cr | ₹1.12 Cr | ₹1.03 Cr | ₹0.89 Cr | ₹0.78 Cr |
| Total Current Liabilities | ₹23 Cr | ₹14 Cr | ₹105 Cr | ₹102 Cr | ₹110 Cr |
| Total Liabilities | ₹135 Cr | ₹285 Cr | ₹483 Cr | ₹202 Cr | ₹222 Cr |
| ASSETS | |||||
| Gross Block | ₹113 Cr | ₹78 Cr | ₹88 Cr | ₹83 Cr | ₹67 Cr |
| Less: Accumulated Depreciation | ₹54 Cr | ₹50 Cr | ₹51 Cr | ₹46 Cr | ₹46 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹60 Cr | ₹28 Cr | ₹37 Cr | ₹38 Cr | ₹21 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹0.01 Cr | - | - | ₹3.55 Cr | ₹4.77 Cr |
| Non Current Investments | - | - | - | - | - |
| Long Term Investment | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Long Term Loans & Advances | ₹0.05 Cr | ₹0.02 Cr | ₹0.11 Cr | ₹0.33 Cr | - |
| Other Non Current Assets | - | - | ₹100 Cr | - | - |
| Total Non-Current Assets | ₹60 Cr | ₹28 Cr | ₹137 Cr | ₹41 Cr | ₹26 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹22 Cr | ₹76 Cr | ₹46 Cr | ₹45 Cr | ₹0.09 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹22 Cr | ₹76 Cr | ₹46 Cr | ₹45 Cr | ₹0.09 Cr |
| Inventories | ₹0.24 Cr | ₹0.71 Cr | - | ₹0.02 Cr | ₹0.14 Cr |
| Raw Materials | ₹0.24 Cr | ₹0.71 Cr | - | - | - |
| Work-in Progress | - | - | - | - | - |
| Finished Goods | - | - | - | - | - |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | - | - | - | ₹0.02 Cr | ₹0.14 Cr |
| Other Inventory | - | - | - | - | - |
| Sundry Debtors | ₹1.34 Cr | ₹1.29 Cr | ₹0.81 Cr | ₹1.30 Cr | ₹1.76 Cr |
| Debtors more than Six months | ₹0.00 Cr | ₹0.01 Cr | - | - | - |
| Debtors Others | ₹1.34 Cr | ₹1.28 Cr | ₹0.81 Cr | ₹1.30 Cr | ₹1.76 Cr |
| Cash and Bank | ₹38 Cr | ₹164 Cr | ₹184 Cr | ₹5.52 Cr | ₹47 Cr |
| Cash in hand | ₹0.01 Cr | ₹0.02 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
| Balances at Bank | ₹38 Cr | ₹164 Cr | ₹184 Cr | ₹5.51 Cr | ₹47 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹1.08 Cr | ₹2.79 Cr | ₹5.12 Cr | ₹8.71 Cr | ₹6.69 Cr |
| Interest accrued on Investments | ₹0.08 Cr | ₹2.20 Cr | ₹4.77 Cr | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹1.00 Cr | ₹0.59 Cr | ₹0.36 Cr | ₹0.43 Cr | ₹0.41 Cr |
| Other current_assets | - | - | - | ₹8.27 Cr | ₹6.28 Cr |
| Short Term Loans and Advances | ₹13 Cr | ₹12 Cr | ₹109 Cr | ₹100 Cr | ₹141 Cr |
| Advances recoverable in cash or in kind | ₹0.01 Cr | - | ₹0.06 Cr | ₹0.02 Cr | ₹0.56 Cr |
| Advance income tax and TDS | ₹1.19 Cr | ₹1.80 Cr | ₹101 Cr | ₹100 Cr | ₹99 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹12 Cr | ₹10 Cr | ₹8.01 Cr | - | ₹41 Cr |
| Total Current Assets | ₹75 Cr | ₹257 Cr | ₹345 Cr | ₹160 Cr | ₹197 Cr |
| Net Current Assets (Including Current Investments) | ₹52 Cr | ₹243 Cr | ₹240 Cr | ₹58 Cr | ₹87 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹135 Cr | ₹285 Cr | ₹483 Cr | ₹202 Cr | ₹222 Cr |
| Contingent Liabilities | ₹6.17 Cr | ₹4.28 Cr | - | - | - |
| Total Debt | - | - | - | ₹0.48 Cr | ₹1.34 Cr |
| Book Value | - | 12.38 | 17.21 | 6.61 | 5.58 |
| Adjusted Book Value | 4.99 | 12.38 | 17.21 | 6.09 | 5.15 |
Compare Balance Sheet of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹4,476.1 Cr | 4% | -11.5% | 56.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,471.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,294.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,946.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,691.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,214.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | 4% |
-11.5% |
56.9% |
| SENSEX | 1% |
3.3% |
4.5% |
You may also like the below Video Courses